Literature DB >> 35462647

Factors Influencing Cervical Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancers.

Sajid S Qureshi1,2, Mufaddal Kazi1, Jarin Noronha1, Vasundhara Smriti2,3, Sandeep Basu4, Sneha Shah2,5, Sanjay Talole6.   

Abstract

Lymph node metastasis is a considerable variable influencing postoperative American Thyroid Association (ATA) risk stratification in pediatric differentiated thyroid cancer (DTC). The primary aim of this study was to ascertain the factors predicting nodal metastasis and describe the outcomes in relation to the ATA risk. Patients 18 years or younger operated between December 2005 and December 2019 were analyzed. Demographic, clinicopathological, treatment, and outcome data were recorded. Factors associated with nodal metastasis were assessed by univariate and multivariate regression analysis. Patients were stratified into low-, intermediate-, and high-risk as per the pediatric ATA guidelines. A total of 86 patients (43% male; median [IQR] age, 12 (10-14) years) underwent surgery during the study period. Lymph node metastases were present in 70 (82.4%) patients involving the lateral (8%) and central compartment (4.7%) alone and both (88.6%) compartments. Extrathyroid extension (ETE) was present in 65%; 35%, minimal; and 30%, extensive. On univariate analysis, nodal metastasis was more frequent in male patients, multifocal tumor, lymphovascular invasion, and ETE. On multivariate analysis, only ETE was predictive of nodal disease with an odds ratio of 8. Minimal and extensive ETEs were both significantly associated with lymph node metastases when compared to the absence of ETE. The 5-year disease-free survival was 100%, 95.7%, and 66% in the low-, intermediate-, and high-risk groups respectively (p < 0.0001). Pediatric DTCs have an exceptionally high incidence of lymph node metastasis. ETE is the single most important predictor of nodal disease. The ATA pediatric risk stratification is useful in predicting clinical outcomes. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Differentiated thyroid cancer; Lymph node metastases; Pediatric; Risk stratification; Treatment outcome

Year:  2021        PMID: 35462647      PMCID: PMC8986908          DOI: 10.1007/s13193-021-01312-w

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  16 in total

Review 1.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

2.  Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence.

Authors:  Brian A Palmer; Abdalla E Zarroug; Rainer N Poley; Joshua P Kollars; Christopher R Moir
Journal:  J Pediatr Surg       Date:  2005-08       Impact factor: 2.545

3.  Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up.

Authors:  Johannes Biko; Christoph Reiners; Michael C Kreissl; Frederik A Verburg; Yuri Demidchik; Valentina Drozd
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-27       Impact factor: 9.236

4.  Predictors of nodal metastasis in pediatric differentiated thyroid cancer.

Authors:  Jina Kim; Zhifei Sun; Mohamed A Adam; Obinna O Adibe; Henry E Rice; Sanziana A Roman; Elisabeth T Tracy
Journal:  J Pediatr Surg       Date:  2016-10-27       Impact factor: 2.545

5.  Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer.

Authors:  Tae Yon Sung; Min Ji Jeon; Yi Ho Lee; Yu-Mi Lee; Hyemi Kwon; Jong Ho Yoon; Ki-Wook Chung; Won Gu Kim; Dong Eun Song; Suck Joon Hong
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

6.  Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation.

Authors:  Nobuyuki Wada; Kiminori Sugino; Takashi Mimura; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Shibuya; Keiko Ohkuwa; Hirotaka Nakayama; Shohei Hirakawa; Norio Yukawa; Yasushi Rino; Munetaka Masuda; Koichi Ito
Journal:  Ann Surg Oncol       Date:  2009-09-24       Impact factor: 5.344

7.  Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.

Authors:  N Wada; K Masudo; H Nakayama; N Suganuma; K Matsuzu; S Hirakawa; Y Rino; M Masuda; T Imada
Journal:  Eur J Surg Oncol       Date:  2007-11-19       Impact factor: 4.424

8.  Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.

Authors:  C Spinelli; F Tognetti; S Strambi; R Morganti; M Massimino; P Collini
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

9.  Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.

Authors:  Yuri E Demidchik; Eugene P Demidchik; Christoph Reiners; Johannes Biko; Mariko Mine; Vladimir A Saenko; Shunichi Yamashita
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

10.  Differentiated thyroid cancer.

Authors:  Ajay Kumar; C S Bal
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.